Accelerated Pharma (ACCP) Files 1.89M Share Common Stock IPO

Accelerated Pharma (Nasdaq: ACCP) filed a registration with the U.S. SEC for an initial public offering of its common stock. The company plans to sell 1,888,889 shares of common stock and sees an offering price of $8 - $10 per share.

The offering will be made through Rodman & Renshaw and Maxim Group.

Accelerated Pharma is a clinical stage biopharmaceutical company focused on utilizing our genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets.

You May Also Be Interested In

• Exclusive: National Vision’s CEO on why the market got post-Q1 selloff wrong
• Diana Shipping raises Genco bid to $27.34 per share
• SOPHiA Genetics closes $57.5M public offering at $4.75 per share